Form 4 for MDXG MIMEDX GROUP, INC.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0001376339-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | 2025-02-13 | MDXG | Whitlow Ricci S | COO | S - Sale | $8.28 | -61.4K | 403.0K | -13% | -$508.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | S | D | 61,420 | $8.28 | 403,019 | D | — | — | (F1) The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. (F2) Includes an aggregate of 4,911 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan |